ASHLAND INC.
At today's price, ASHLAND INC. (ASH) is priced for today's economics sustained for ~9.7 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Ashland is a specialty chemicals company weighted toward Life Sciences and Personal Care, segments that together make up about two-thirds of the business and earn high-margin, recipe-driven economics. • The trailing income statement looks ugly because of a non-cash impairment, but the underlying business still produced an adjusted EBITDA margin near 20% in fiscal Q2 2026, the better read on its earning power [Source: Q2 FY2026 results, April 2026]. • The near-term challenge is execution and de
Is ASH overvalued? See what's priced in →
334 institutional managers reported holding ASH in 13F filings for the quarter ended 2026-03-31. 48 opened new positions that quarter. Held by Vanguard Group, BlackRock, MFS Investment Management, among others. On the short side, 5.6M shares were sold short as of the 2026-06-15 count, about 12% of shares outstanding (4.8 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
ASH has cut its share count 24.6% over the past five years, spending $2.26B on repurchases. It pays a dividend, and has paid one every year in our records (12 and counting), raised 7 years straight; the current rate is $1.64 a share annually. Cash returned over the past three years: $384.00M in dividends and $1.11B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at ASH over the trailing three years: 2025: 2 buys totaling $2.21M. 14 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ASH's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-28 | +0.1% | -11.0% |
| 2023-11-18 | +0.6% | +2.8% |
| 2024-02-01 | +15.9% | +0.9% |
| 2024-05-02 | -2.6% | -2.8% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ASH's latest 8-K filings: 2026-05-29 (items 1.01, 2.03, 9.01); 2026-05-18 (items 5.02, 9.01); 2026-04-28 (items 2.02, 7.01, 9.01); 2026-02-02 (items 2.02, 7.01, 9.01); 2026-01-27 (items 5.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.